Open an account

Teladoc Health

TDOC · NYSE

$6.21+$0.48 (+8.38%)TodayMarket closed ·
Prev close $5.73

About TDOC

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. The company is headquartered in New York City, New York and currently employs 5,600 full-time employees. The company went IPO on 2015-07-01. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

Employees
5,600
Headquarters
New York City, New York
Listed
Jul 1, 2015
Sector
Health Care
Industry
Health Care Technology
Website
teladochealth.com

TDOC key statistics

Market cap
1.13B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.54M
Volume
4.78M
Open price
$5.80
High today
$6.27
Low today
$5.76
52 Week high
$9.89
52 Week low
$4.40

Teladoc Health (TDOC) at a glance

As of Oct 20, 2026, Teladoc Health (TDOC) shares are priced at $6.21, giving the company a market cap of 1.13B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $5.76 and $6.27. The current price is 7.8% above the day's low and 1.0% below its high.

Volume so far is 4.78M shares, above the average of 3.54M shares a day.

Over the past year Teladoc Health has ranged from $4.40 to $9.89, and now sits 33% of the way up that range.

Teladoc Health met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.21 per share against an estimate of -$0.2549.

The average analyst price target is $7.79, 25.5% above the current price, from 14 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

36%of 14 analyst ratings say Buy
  • Buy35.7%
  • Hold64.3%
  • Sell0.0%
Price target · 21 analystsAvg $7.79
Low
$5.55
Now
$6.21
High
$11.02

TDOC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 26.4% on average.

  1. Q3 FY24: reported -$0.19 per share against an estimate of -$0.2812
  2. Q4 FY24: reported -$0.28 per share against an estimate of -$0.2448
  3. Q1 FY25: reported -$0.53 per share against an estimate of -$0.3437
  4. Q2 FY25: reported -$0.19 per share against an estimate of -$0.2664
  5. Q3 FY25: reported -$0.28 per share against an estimate of -$0.2714
  6. Q4 FY25: reported -$0.14 per share against an estimate of -$0.1915
  7. Q1 FY26: reported -$0.36 per share against an estimate of -$0.3196
  8. Q2 FY26: reported -$0.21 per share against an estimate of -$0.2549

TDOC news

  • Press releaseGlobe Newswire

    Teladoc Health to Announce Third Quarter 2026 Financial Results

  • Neeraj Jain

    Teladoc Turns Smartphone Cameras Into AI-Powered Vital Sign Monitors

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Teladoc Health, Inc. – TDOC

  • Press releasePRNewswire

    Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

Similar companies

Companies in the same industry as Teladoc Health

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.